Showing results (101-110 of 2,599) with videos related to

Sort By:
Pageof 260
The American Journal of Psychiatry|August 1, 1996
Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapineA K Malhotra, D Goldman, N Ozaki, et al.
Psychopharmacology|January 1, 1993
Clinical investigation of monoamine neurotransmitter interactionsJ K Hsiao, W Z Potter, H Agren, et al.
The American Journal of Psychiatry|May 1, 1984
Plasma cortisol and beta-endorphin immunoreactivity in nonmajor and major depressionM R Cohen, D Pickar, I Extein, et al.
Biological Psychiatry|July 1, 1990
Effects of the acute administration of caffeine in patients with schizophreniaP B Lucas, D Pickar, J Kelsoe, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 1, 1992
Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal manD S Goldstein, A Breier, O M Wolkowitz, et al.
Archives of General Psychiatry|May 1, 1982
Selective and nonselective monoamine oxidase inhibitors: behavioral disturbances during their administration to depressed patientsD Pickar, D L Murphy, R M Cohen, et al.
Archives of General Psychiatry|June 1, 1983
High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responsesM R Cohen, R M Cohen, D Pickar, et al.
Psychiatry Research|February 1, 1983
High-dose naloxone affects task performance in normal subjectsR M Cohen, M R Cohen, H Weingartner, et al.
Annals of the New York Academy of Sciences|January 1, 1985
The effects of cholecystokinin-like peptides in schizophrenics and normal human subjectsD W Hommer, D Pickar, J N Crawley, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1990
Neurochemical and neural mechanisms of positive and negative symptoms in schizophreniaD Pickar, R E Litman, P E Konicki, et al.
Pageof 260